Molina Healthcare, Inc. (NYSE:MOH) Director Charles Z. Fedak sold 4,487 shares of the business’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $72.55, for a total value of $325,531.85. Following the sale, the director now directly owns 20,648 shares of the company’s stock, valued at approximately $1,498,012.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Molina Healthcare, Inc. (MOH) opened at $72.12 on Friday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.29 and a current ratio of 1.35. Molina Healthcare, Inc. has a one year low of $42.56 and a one year high of $93.98. The company has a market capitalization of $4,304.84, a PE ratio of 24.61, a price-to-earnings-growth ratio of 1.31 and a beta of 1.10.
Large investors have recently added to or reduced their stakes in the stock. Amundi Pioneer Asset Management Inc. acquired a new position in shares of Molina Healthcare in the fourth quarter worth about $100,000. Zions Bancorporation acquired a new position in shares of Molina Healthcare in the third quarter worth about $118,000. Tiedemann Wealth Management LLC lifted its stake in shares of Molina Healthcare by 7.8% in the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after acquiring an additional 103,775 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Molina Healthcare by 40.3% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after acquiring an additional 690 shares in the last quarter. Finally, Connable Office Inc. acquired a new position in shares of Molina Healthcare in the fourth quarter worth about $203,000. Institutional investors and hedge funds own 96.22% of the company’s stock.
A number of equities research analysts have issued reports on MOH shares. ValuEngine raised Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research cut Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 9th. Jefferies Group boosted their price objective on Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research note on Friday, November 3rd. Raymond James Financial restated a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Finally, BMO Capital Markets reduced their price objective on Molina Healthcare from $98.00 to $85.00 and set a “market perform” rating on the stock in a research note on Wednesday. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $73.73.
WARNING: This report was first reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.thelincolnianonline.com/2018/02/18/insider-selling-molina-healthcare-inc-moh-director-sells-4487-shares-of-stock.html.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.